Congress is expected to make a major push in the next few months to approve dozens of bipartisan bills to combat the opioid epidemic.

But missing from this effort is a bill to reverse a 2016 law that weakened the Drug Enforcement Administration’s power to go after suspicious drug distributors.

Recommended Stories

House committee advances opioid bill senators call ‘weak’

Orrin Hatch tears into Washington Post opioids report: It’s meant to derail Trump’s drug czar nominee

Thanks to Congress, we’re making real progress in the opioid crisis